End-stage renal disease, atherosclerosis, and cardiovascular mortality: Is C-reactive protein the missing link?

Abstract

In uremic patients, the morbidity and mortality of cardiovascular disease are substantially higher than in the general population. This has led to the formulation of an 'accelerated atherogenesis' hypothesis in uremic patients and has been commonly linked with the metabolic alterations associated with uremia. Advancement in the understanding of the pathogenesis of atherosclerotic vascular disease now suggests a central contribution of inflammation to atherogenesis, with involvement of a number of key mediators and markers of the inflammatory process. Recent epidemiological data have documented associations between C-reactive protein (CRP), the prototypical acute phase response protein, and cardiovascular disease in general population. Given the lipoprotein binding and complement activation functions of CRP and its localization in atherosclerotic vessels, there is a strong likelihood that CRP may be involved in the atherosclerotic process. The uremic state is associated with an altered immune response, which is associated with elevated proinflammatory cytokine levels. CRP concentrations are increased in a significant proportion of end-stage renal disease patients and have been associated with certain clinical outcome measures, including all-cause and cardiovascular mortality. This review outlines the evidence linking CRP with atherosclerosis and proposes that elevated CRP concentrations may be involved in the initiation and progression of accelerated atherosclerosis in uremia.

Rosuvastatin in Diabetic Hemodialysis Patients

“…29,30 hsCRP was elevated at baseline in our patients, the level of 5 mg/L was identical to the level of hsCRP at inclusion of patients into the 4D study. 29 In 4D, treatment with atorvastatin had a minimal effect on hsCRP level and this was modestly lowered by 10.9% in the treatment arm in our study.…”

Skin Autofluorescence–Indicated Advanced Glycation End Products as Predictors of Cardiovascular and All‐Cause Mortality in High‐Risk Subjects: A Systematic Review and Meta‐analysis

“…The crucial role of chronic hyperglycemia in the development and progression of atherosclerosis and CVD events in patients with diabetes mellitus or renal disease is not debatable 38, 39, 40. However, the identification of AGEs in the atherosclerotic plaques of nondiabetic patients with coronary artery disease have magnified the importance of AGEs and oxidative stress in accelerating atherosclerosis 41.…”

Presence of a Failed Kidney Transplant in Patients Who Are on Hemodialysis Is Associated with Chronic Inflammatory State and Erythropoietin Resistance

“…Many epidemiologic studies have shown an association between CRP and arteriosclerosis, thereby establishing a possible link among inflammation, arteriosclerosis, and malnutrition in patients with kidney disease (13,27,28). Thus, patients who have failed kidney transplants and are on HD exhibit a constellation of hematologic and biochemical abnormalities characteristic of a chronic inflammatory state, which is associated with increased morbidity and mortality.…”